HIV mutation literature information.


  Transmitted Drug Resistance Mutations in Antiretroviral-Naive Injection Drug Users with Chronic HIV-1 Infection in Iran.
 PMID: 25962088       2015       PloS one
Table: D67N
Discussion: In contrast to these earlier reports that identified a limited number of NRTI mutations (T215D, K219Q and D67G, V75A) with a low overall frequency (4.2% and 5.1%, respectively) in newly infected Iranian cases, we detected a variety of NRTI SDRMs (M41L, D67N, K70R, V75M, F116Y, M184V, L210W, T215Y, and K219E) with a higher overall frequency (10%) in chronically infected IDUs in the city of Sanandaj (Table 2).


  Prediction of drug-resistance using genotypic and docking analysis among anti-retroviral therapy naive and first-line treatment failures in Salem, Tamil Nadu, India.
 PMID: 25892414       2015       Current HIV research
Abstract: The mutations of I135R/T/V/X, L178 I/M, M184V/I, D67N, K70R, and K103N were the most common among these 23 patients.


  Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
 PMID: 25849352       2015       PLoS medicine
Method: Thymidine-analog mutations (TAMs) were defined as the NRTI SDRMs M41L, D67N/G/E, K70R, L210W, T215Y/F/S/C/D/E/I/V, and K219Q/E/N/R.
Result: Of the 34 NRTI SDRMs, 16 occurred in >=0.1% of the 50,870 viruses from all regions: most commonly M184V, the TAMs (M41L, D67G/N, K70R, L210W, T215F/Y, K219E/Q), the T215 revertants (T215C/D/


  AZT resistance alters enzymatic properties and creates an ATP-binding site in SFVmac reverse transcriptase.
 PMID: 25808094       2015       Retrovirology
Introduction: Amino acid sequence alignments of the polymerase domains of SFVmac and HIV-1 revealed that the SFVmac AZT resistance mutations do not correspond to the ones obtained with highly AZT-resistant HIV-1 RT (M41L, D67N, K70R, T215Y/F and K219Q/E).


  Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations.
 PMID: 25765644       2015       Nucleic acids research
Result: Additionally, MNVs emerged in HIVWT during single-cycle infections, with the most frequent MNV located at nucleotide 2744 (RT codon 65) culminating in the emergence of K65K and D67N
Discussion: D67N relative to WT in the presence of ZDV), over multiple cycles of replication in vivo these small fitness gains are likely to be amplified and have clinical implications.
Discussion: Drug resistance mutations change the primary sequence of HIV-1, which can alter the length of homopolymeric stretches of nucleotides, as is the case for D67N in subtype B.


  Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations.
 PMID: 25765644       2015       Nucleic acids research
Result: Accordingly, we examined whether the TAMs D67N/K70R increase errors introduced by HIV-1 RT during intracellular RTn that are alleviated by silent mutations K65K and K66K.
Result: Accordingly, we investigated whether HIV-1 harboring K65K or K66K (AAA to AAG change) in the presence of the TAMs, D67N and K70R (HIVTAMK65K and HIVTAMK66K, respectively), potentiated resistance to RT inhibitors.
Result: Based on our previous data showing that K65K and K66K alleviate pausing of recombinant HIV-1 RT during cDNA synthesis of a synthetic RN


  Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.
 PMID: 25754408       2015       Journal of medical virology
Result: A wide range of mutations conferring multi-NRTI resistance were also observed, including M41L (n = 7, 10%), A62V (n = 15, 22%), D67N (n = 10, 15%), K70R (n = 10, 15%), V75I (n = 2, 3%), F77L (n = 1, 1%), Y115F (n = 6, 9%), F116Y (n = 1, 1%), Q151M (n = 1, 1%), L210W (n = 3, 4%), T215Y/F (n = 7, 10%) and (n = 5, 7%), and K219Q/E (n = 4, 6%) and (n = 7, 10%).


  Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
 PMID: 25711326       2015       HIV medicine
Abstract: The most frequent TDR mutations observed were M41L, D67N/G/E, T215F/Y/I/S/C/D/E/V/N, 219Q/E/N/R, K103N/S, and G190A/S/E in reverse transcriptase, and M46I/L and L90M in protease.


  Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses.
 PMID: 25680310       2015       Clinical microbiology and infection
Abstract: The most common TC-DRM present in >=50% of them were D67NME, T215FVY, M41L and K103N (retrotranscriptase) and L90M (protease).


  Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naive and treated pediatric patients.
 PMID: 25674767       2015       Viruses
Table: D67N



Browser Board

 Co-occurred Entities




   Filtrator